Voriconazole Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 50 mg, 200 mg
Reference Brands: Vfend(US & EU)
Category: Anti-fungal
Voriconazole tablets inhibit fungal cytochrome P450 14α-demethylase, disrupting ergosterol synthesis and fungal cell membrane formation. They provide broad-spectrum antifungal activity, including against Aspergillus and Candida. Benefits include oral administration, excellent tissue penetration, rapid action, and high efficacy in treating invasive fungal infections, improving patient outcomes. Voriconazole Tablets is available in Tablets and strengths such as 50 mg, 200 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Voriconazole Tablets is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Voriconazole Tablets can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description:
Voriconazole tablets are approved in the EU and US for treating invasive fungal infections. In the EU, Pfizer’s Vfend is regulated by EMA, supported by dossiers demonstrating safety, efficacy, and quality. In the US, FDA approval is based on comprehensive clinical data, biosimilarity, and pharmacovigilance. Both regions require detailed dossiers for initial authorization and ongoing safety monitoring. For expert assistance with pharmaceutical dossiers, regulatory submissions, and compliance, visit PharmaTradz, your trusted partner in regulatory solutions. We help ensure smooth market access and adherence to European and American standards for voriconazole tablets, supporting your product’s global success.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Voriconazole is used to treat serious fungal infections, particularly invasive aspergillosis, candidemia, esophageal candidiasis, and infections caused by Scedosporium and Fusarium species. It is often prescribed for immunocompromised patients and is known for its broad-spectrum antifungal activity and strong efficacy.
Voriconazole contains the active triazole antifungal compound voriconazole. It is formulated with suitable pharmaceutical excipients designed to enhance absorption, stability, and bioavailability depending on the dosage form.
The main trade name for voriconazole is Vfend, widely marketed in the USA, EU, UK, and other global regions.
Vfend is manufactured by Pfizer. Generic versions of voriconazole are also produced by several GMP-certified manufacturers across different international markets.
The generic name is voriconazole.
The primary brand name is Vfend.
Voriconazole is manufactured in Pfizer’s regulated facilities in the USA and Europe, along with multiple GMP-approved pharmaceutical companies that produce generic voriconazole for global supply.
Related Products
Naftifine Hydrochloride
Strength:
1 %, 2%
Form: Cream / Gel
Reference Brands: Naftin (USA), Xolafin (USA)
View Details
Sertaconazole Nitrate
Strength:
2 %
Form: Creams
Reference Brands: Ertaczo (USA), Zalain (EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
